Closing Bell: Nervgen Pharma Corp up on Monday (NGEN)

In today's trading, shares of Nervgen Pharma Corp opened at $2.02 and closed at $2.36. prices ranged from $2.02 to $2.37.

Share prices advanced 18.00% from the previous day's close of $2.00.

Today across North America, the TSX Composite closed 0.29% at 22069.76, the S&P 500 closed -0.11% at 5346.99, the Dow Jones Industrial Average closed -0.22% at 38798.99 and the Nasdaq Composite closed -0.23% at 17133.13.

Nervgen Pharma Corp has listed on the Toronto Venture Exchange (TSX-V) under the ticker NGEN.

A total of 367,707 shares was traded during the last trading day, with total trades of 559, with an average volume of 126,215 over the last 5 days.

The TSX-V market on the whole today saw 2,628 price advancers against 2,551 declines and 106 unchanged.

During the prior 52 weeks, NGEN.VN has traded as high as $3.98 (February 05,2024) and low as $1.58 (December 14,2023). Moreover, the shares have boosted 38.01 percent in the last 12 months, while this year, they have dipped -12.59%.

Following today's trading, Nervgen Pharma Corp has a market capitalization of $139.85 million on a float of 69,928 shares outstanding. Its annual EPS is $-0.34.

Nervgen Pharma Corp is a TSX Biotechnology company headquartered in Vancouver, CAN.

Currently, Nervgen Pharma Corp's consensus rating is "Strong Sell" based on 0 analysts according to Zacks. From those 0 analysts,.

AI at The Globe and Mail
This report is produced using automated technology that summarizes market data into articles for our readers. Ongoing project experiments that leverage artificial intelligence include valuation screens across 14 categories and end-of-day Closing Summary reports for all North American securities..